BioMADE Community Capabilities Webinar | Downstream Processing – A Focus on Spray Drying and Fluid Bed Processing

AVEKA Group was founded in 1994 as a spin off from 3M as a particle processing company. The company has focused on developing and manufacturing particulate materials with novel and value-added attributes for the personal care, food, automotive, and industrial chemical markets. An overview of AVEKA and its approach to collaborative contract development and manufacturing will be presented by AVEKA’s CEO, Willie Hendrickson. This close co-development of new processes and novel materials with customers will focus on the use of down stream drying processing for biological materials and be discussed with respect to the potential to fast-track economic pathways to production. This will include examples where scale-up development time (transition through the development valley of death) was dramatically shortened, and production costs were minimized. Fundamental explanation of both spray drying and fluid bed drying will also be presented. Examples will include spray drying of fermented materials, neutralized short chain fatty acids, and cellulose fibers; extraction and spray drying of biological value-added components; and fluid bed drying and agglomeration of enzymes, yeasts, and proteins.

Biography – Willie Hendrickson
Willie is the founder and CEO of AVEKA Group. AVEKA was founded in 1994 as a spin off from 3M and comprises four manufacturing sites and 200 people for industrial, chemical, and food contract manufacturing and process development of particulate materials. Prior to starting AVEKA, Willie worked at 3M as a manager for particle processing. Willie received his Ph.D. from the University of Florida in organometallic synthesis. He is a past President of the International Fine Particle Research Institute and has been an adjunct professor at the University of Minnesota in the Chemical Engineering and Food Science Departments. He has authored or coauthored over 20 technical papers and is the current holder of 60 issued or applied for US patents.

Members, find all webinar recordings here.

Previous
Previous

BioMADE Community Capabilities Webinar | From Feedstock to Scale: UC Davis's Integrated Approach to Biomanufacturing

Next
Next

BioMADE at Chemical Innovation Exchange Conference (CIEX)